Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
Sale, Matthew J., Minihane, Emma, Monks, Noel R., Gilley, Rebecca, Richards, Frances M., Schifferli, Kevin P., Andersen, Courtney L., Davies, Emma J., Vicente, Mario Aladren, Ozono, Eiko, Markovets, AVolume:
10
Language:
english
Journal:
Nature Communications
DOI:
10.1038/s41467-019-12409-w
Date:
December, 2019
File:
PDF, 4.58 MB
english, 2019